IntegenX designs, manufactures and markets automation systems enabling reliable microsample preparation and analysis for the life sciences. Sample preparation processes can be complex and expensive, and researchers must choose to use complex manual procedures or expensive, large robotic systems. There is also a fundamental mismatch between the volume real world samples present in (as large as 10 ml/ 10-2 liters) and the volumes used by modern analytical instrumentation (as little as 10-9 liters). This mismatch wastes large amounts of expensive consumables and precious samples. IntegenX has developed technologies aimed at simplifying sample preparation, addressing the issue of volume scale and ultimately developing complete ’sample-to-answer solutions’ SM with a much smaller footprint than is available today.

IntegenX has proprietary and patented technology to scale large sample volumes to efficient nanoscale solutions that will ultimately reduce labor costs, increase reliability, and provide major savings in highly expensive reagents and scarce samples.

{ Comments on this entry are closed }

IntegenX, Inc. Appoints Debi Frost to Vice President of Operations

IntegenX, Inc. today announced the appointment of Debi Frost as Vice President of Operations. Ms. Frost will be responsible for the company’s operational organization and infrastructure, and will report to Stevan Jovanovich, Ph.D., President and Chief Executive Officer of IntegenX. Prior to joining IntegenX, Ms. Frost earned positions of increasing operational responsibility over the course [...]

more →

IntegenX, Inc. Opens New Headquarters and Manufacturing Facility with Open House Celebration

Congressman Jerry McNerney Congratulates Tri-Valley Manufacturer of Biotechnology Equipment at Ribbon-Cutting Ceremony IntegenX, Inc. (formerly Microchip Biotechnologies, Inc.), today announced the grand opening of its new corporate headquarters and high-tech manufacturing facility at 5720 Stoneridge Drive, Pleasanton, California, in the Hacienda Business Park. In attendance at the event’s ribbon-cutting ceremony and open-house celebration were the [...]

more →

Microchip Biotechnologies Changes Name to IntegenX

Microchip Biotechnologies, a maker of automated microscale biotech laboratory systems, today announced that it has changed its business name to IntegenX. The new name acknowledges the company’s focus on integrating sample preparation and analysis technologies into complete products that address generic problems shared by life science and biotechnology research laboratories worldwide. Under its new name, [...]

more →

Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President

The new position of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, Inc. has been taken up by Howard Goldstein, a biotech lab systems executive with more than 30 years of experience creating and managing life science product organizations. Mr. Goldstein will direct Microchip Biotechnologies’ marketing, business development, sales and customer service operations as the [...]

more →

Microchip Biotechnologies Raises $18.1m In Series B Financing

Microchip Biotechnologies, Inc.(MBI), a provider of integrated life science systems for microsample preparation and analysis, today announced an $18.1M close of its Series B financing. The capital will fund the commercialization of the Apollo 100 System, a sample preparation system for Sanger DNA cycle sequencing, and the development of the Apollo platform for the rapidly [...]

more →

André Marion joins Microchip Biotechnologies’ Board of Directors

Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for life sciences, announced today that André F. Marion has accepted a board position to its Board of Directors, effective immediately. Mr. Marion was former CEO of Applied Biosystems and today serves on the boards of several venture capital backed companies. “André Marion brings [...]

more →

Ezra Van Gelder joins Microchip Biotechnologies as Executive Vice President R&D

Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for Life Sciences, announced today that Ezra Van Gelder has joined its team as Executive Vice President of R&D. Ezra Van Gelder brings Microchip Biotechnologies (MBI) extensive leadership experience in research and development from the life science, medical device and semiconductor equipment industries. Prior [...]

more →

Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program

Microchip Biotechnologies, Inc. (MBI) has been awarded a $625,000 contract under the inaugural US Army Commercialization Pilot Program for the development of a Universal Sample Preparation Module (USPM). The Commercialization Pilot Program is a new program to assist SBIR firms that have Phase II projects that meet high priority Army requirements in transitioning to commercial [...]

more →

Microchip Biotechnologies, Inc. Enters into License Arrangement with GE Healthcare for Fundamental Microfluidic Patents

Microchip Biotechnologies, Inc. (MBI) announces that it has entered into a multi-patent license agreement with GE Healthcare that significantly enhances MBI’s intellectual property portfolio supporting the development of lab-on-a-chip devices.   The patents cover design and methods for creating integrated fluidic microchip devices. “Licensing these fundamental patents continues to build our strong intellectual property position in [...]

more →